A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection
NCT: NCT05300464 · RECRUITING
Brief Summary
This is a multicentric, single arm, prospective, stratified by breast density clinical investigation to confirm the ability of the microwave mammogram 'MammoWave' to detect breast lesions. MammoWave is a innovative medical device, class IIa marked CE, which uses microwaves instead of ionazing radiation (x-ray) for breast lesions. Specifically MammoWave employs a novel technique wich generates images by processing very low power (\<1mW) microwave. The MammoWave exam takes few minutes for breast and is performed with the patient lying in a confortable facing down position. MammoWave is safe to be used at any age, in any condition (pregnancy, specific illness and for unlimited number of times.
Frequently Asked Questions
What is A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection?
A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection is a clinical trial registered under NCT05300464. Current status: RECRUITING.
What is the status of NCT05300464?
The current status of NCT05300464 (A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection) is: RECRUITING.
When did A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection start?
A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection started on 2023-01-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.